Global Vaccine Production Drives Pharmaceutical CDMO Market

Pharmaceutical CDMO market to grow at 7.29% CAGR by the year 2028, influenced by analytics, CMO-CRO transformation, COVID-19 impact, and Asia-Pacific expansion.

Small Molecule Innovator CDMO Market Poised For Huge Growth

Projected to hit USD 76.5B by 2031, the Small Molecule Innovator CDMO Market growth is fueled by cancer demand, outsourcing, and technological advancements.

Unlocking Value-Based Pricing Strategies In Pharma CDMOs

CDMOs in the pharma sector must overhaul pricing strategies, adopt value-based models, and offer comprehensive end-to-end solutions for optimal competitiveness.

Overcoming Challenges In Biopharma Novel Drug Manufacturing

Biopharma sector transforms with novel modalities for complex diseases, demanding adaptable teams and capable CMOs for successful development and compliance.

Biologics Fuel Demand For Aseptic Fill-Finish Manufacturing

Rising medicine spending boosts demand for aseptic fill-finish manufacturing, ensuring drug purity and efficacy, driven by biologics and strict regulations.